CN
About US

    Shanghai Biomed-Union Biotechnology Co., Ltd. was founded by the chairman of Mr. Wuguoxiang in 2010 with a registered capital of RMB 60 million . As one of the hanghai high-tech enterprises,the company specializes in the research and clinical application of new techniques for tumor treatment、medical cooperation 、 patient services at home and abroad .

Parterners /

Nijihashi Hospital, Japan(虹橋クリニック

Hongqiao hospital is located in the metropolitan area of Tokyo, Japan. As a general hospital featuring cancer immunotherapy, it has advanced immunocyte culture, amplification and treatment technology. The hospital has advanced CPC cell laboratory, high-end cell culture and quality testing equipment, and has a complete certification of the Ministry of Health and Health.

Hainan Boao Lecheng International Medical Tourism Pilot Zone

Hongqiao hospital is located in the metropolitan area of Tokyo, Japan. As a general hospital featuring cancer immunotherapy, it has advanced immunocyte culture, amplification and treatment technology. The hospital has advanced CPC cell laboratory, high-end cell culture and quality testing equipment, and has a complete certification of the Ministry of Health and Health.